Marker Therapeutics Inc (MRKR)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
19,174,100
EV to revenue ratio (TTM)
0.199
EV to ebitda
-0.218
Financial Performance
Revenue (TTM)
3,546,700
Gross profit (TTM)
-5,258,892
EBITDA
-11,792,272
Profitability
Operating margin (TTM)
-267.90%
Profit margin
-245.50%
Return on assets (TTM)
-40.50%
Return on equity (TTM)
-76.90%
Per Share Metrics
Revenue per share (TTM)
0.19
EPS
-0.38
Diluted EPS (TTM)
-0.38
Book value
0.73
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
5.41
Price to book ratio (TTM)
1.7
Growth
Quarterly earnings growth (YoY)
-51.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
3
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.534